A registry study of multiple system atrophy in Hokkaido, Japan: HoRC-MSA Project 2014-16
Objective: To investigate the epidemiological aspects of multiple system atrophy (MSA) in Hokkaido, Japan by using the Hokkaido Rare disease Consortium for MSA (HoRC-MSA). Background:…Cognitive Impairment in MSA Patients from the Catalan Multiple System Atrophy Registry (CMSAR)
Objective: To assess the cognitive function and its demographic and clinical correlates in MSA patients included in the Catalan Multiple System Atrophy-Registry (CMSAR). Background: Cognitive…Randomize study of occurrence of Parkinson’s syndrome in patients with rheumatoid arthritis.
Objective: We aimed to study an occurrence of Parkinson’s syndrome (PS), its relationship with duration of disease and age of patients with rheumatoid arthritis. Background:…Association of nocturnal stridor with clinical features of patients with multiple system atrophy
Objective: To investigate the association between findings of night video-polysomnography and clinical feature of patients with multiple system atrophy (MSA). Background: Nocturnal sleep-related clinical sympotoms…[11C]PK11195 PET in Alzheimer’s disease and progressive supranuclear palsy: the NIMROD study
Objective: Here we test whether the intensity and regional distribution of neuro-inflammation differs between Alzheimer's disease (AD), Progressive Supranuclear Palsy (PSP) and controls; and whether neuro-inflammation…To Study the Role of Biomarkers DJ-1 and Apo A1 in Idiopathic Parkinson’s Disease and Parkinson Plus Syndromes in Indian Population
Objective: To study the role of serum DJ-1 and Apo A1 in the diagnosis and differentiation of Idiopathic Parkinson Disease (IPD) and Parkinson Plus Syndromes(PPS)…The utility of post-void residual volume versus sphincter electromyography to distinguish between multiple system atrophy and Parkinson’s disease
Objective: To determine the ability of sphincter electromyography (EMG) and post-void residual urine volume (PVR) during a free-flow study and a pressure-flow study (PFS) for…Cerebrospinal Fluid Levels of Coenzyme Q10 are Reduced in Multiple System Atrophy
Objective: To assess CSF levels of coenzyme Q10 in multiple system atrophy (MSA) vs. Parkinson’s disease (PD), progressive supranuclear palsy (PSP), and control subjects without…Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy
Objective: We aimed to develop AAV-based models of MSA Background: Multiple system atrophy (MSA) is a fatal neurodegenerative disorder characterized by a combination of autonomic…The predictor factors for survival in Chinese Multiple System Atrophy patients
Objective: Our aim was to explore the predictors of survival in Chinese multiple system atrophy (MSA) patients. Background: MSA is a rare, fatal neurodegenerative disorder with…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.